Get the Stockscreener App
13.49
0.88%
-0.12
Certara Inc stock is traded at $13.49, with a volume of 427.92K.
It is down -0.88% in the last 24 hours and up +20.12% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$13.61
Open:
$13.61
24h Volume:
427.92K
Relative Volume:
0.35
Market Cap:
$2.19B
Revenue:
$363.55M
Net Income/Loss:
$-78.68M
P/E Ratio:
-26.98
EPS:
-0.5
Net Cash Flow:
$50.74M
1W Performance:
-5.20%
1M Performance:
+20.12%
6M Performance:
+3.53%
1Y Performance:
-18.34%
1-Day Range:
$13.44
$13.90
1-Week Range:
$13.38
$14.48
52-Week Range:
$9.41
$19.87
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
13.48 | 2.19B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
236.06 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.12 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
78.52 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
68.50 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
111.73 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Financial Metrics Unveiled: Certara Inc (CERT)’s Key Ratios in the Spotlight - The Dwinnex
Wall Street analysts’ outlook for Certara Inc (CERT) - SETE News
How To Trade (CERT) - Stock Traders Daily
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences - The Manila Times
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 - The Bakersfield Californian
Certara's Triple Event: Q4 Results and Two Major Healthcare Conference Appearances Ahead - StockTitan
Certara, Inc. (NASDAQ:CERT) Receives Consensus Rating of “Hold” from Analysts - Defense World
Certara, Inc. (NASDAQ:CERT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Comparing PLAYSTUDIOS (NASDAQ:MYPS) and Certara (NASDAQ:CERT) - Defense World
Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerink’s Target Price Boost to $13 - MSN
Riverbridge Partners LLC Cuts Stock Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Top 10 Medical AI Stocks on Wall Street’s Radar - Insider Monkey
Exploring High Growth Tech Stocks in January 2025 - Simply Wall St
Certara (NASDAQ:CERT) Trading 7.4% HigherShould You Buy? - MarketBeat
Certara Inc (CERT) Shares Up 5.79% on Jan 22 - GuruFocus.com
FY2024 Earnings Forecast for Certara Issued By William Blair - Defense World
FY2024 EPS Estimates for Certara Lifted by Leerink Partnrs - Defense World
FY2024 Earnings Estimate for Certara Issued By William Blair - MarketBeat
Leerink Partnrs Issues Positive Outlook for Certara Earnings - MarketBeat
CERTCertara, Inc. Latest Stock News & Market Updates - StockTitan
Harbor Capital Advisors Inc. Lowers Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Barclays PLC Has $825,000 Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara, Inc. (NASDAQ:CERT) Shares Acquired by Barclays PLC - MarketBeat
Certara, Inc. Provides Preliminary Financial Guidance for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Certara (NASDAQ:CERT) Shares Up 10.4%What's Next? - MarketBeat
Kopion Asset Management LLC Has $5.92 Million Holdings in Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara Surpasses Revenue Expectations in Q4 - AskTraders
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Certara Reports Strong Q4: Software Revenue Surges 24% as Total Revenue Hits $99.7M - StockTitan
Certara Inc (CERT) Stock Price Down 4.01% on Jan 14 - GuruFocus.com
Certara (NASDAQ:CERT) Trading Down 3.4%Here's What Happened - MarketBeat
GAMMA Investing LLC Has $90,000 Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara, Inc.'s (NASDAQ:CERT) Share Price Not Quite Adding Up - Simply Wall St
Certara (NASDAQ:CERT) Will Be Hoping To Turn Its Returns On Capital Around - Yahoo Finance
JPMorgan Chase & Co. Sells 176,780 Shares of Certara, Inc. (NASDAQ:CERT) - MarketBeat
JPMorgan Chase & Co. Has $45.35 Million Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Certara To Participate In The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Certara to Present at J.P. Morgan Healthcare Conference 2025: Key Investor Event - StockTitan
Principal Financial Group Inc. Cuts Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Barclays PLC Buys 46,880 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Short Interest in Certara, Inc. (NASDAQ:CERT) Decreases By 13.9% - MarketBeat
Certara, Inc. (NASDAQ:CERT) Receives $15.92 Consensus Price Target from Analysts - MarketBeat
Certara, Inc. (NASDAQ:CERT) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Certara, Inc. (NASDAQ:CERT) Holdings Raised by Jane Street Group LLC - Defense World
HighTower Advisors LLC Decreases Stock Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Franklin Resources Inc. Reduces Position in Certara, Inc. (NASDAQ:CERT) - MarketBeat
State Street Corp Acquires 122,411 Shares of Certara, Inc. (NASDAQ:CERT) - MarketBeat
Certara (NASDAQ:CERT) Stock Price Down 4.6%Here's What Happened - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.64 Million Stock Holdings in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara, Inc. (NASDAQ:CERT) Shares Sold by Janus Henderson Group PLC - MarketBeat
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS |
Oct 04 '24 |
Option Exercise |
0.00 |
7,151 |
0 |
57,242 |
8.77%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):